After obtaining accreditation from the China National Accreditation Service for Conformity Assessment (CNAS), the Macao Centre for Testing of Chinese Medicine, University of Macau (MCTCM, UM) has actively strengthened its connection with renowned pharmaceutical companies in Macao and Hengqin to better understand the industry’s demand for Chinese medicine testing and to explore the development of the Chinese medicine industry in Macao.

Representatives from several pharmaceutical companies in Macao and Hengqin visited MCTCM for exchanges. They were satisfied with the centre’s development, equipment, facilities, and testing capabilities, and expressed their desire to strengthen cooperation with the centre. Li Shaoping, director of MCTCM, said that Macao is a bridgehead for Chinese medicine to go global, and MCTCM is a bridge between industry and academia. The fundamental mission of the centre is to provide technical assistance to the Pharmaceutical Administration Bureau of Macao, conduct registration testing and monitor testing, and contribute to the industrialisation and internationalisation of Chinese medicine in Macao. To date, 118 items tested by MCTCM have passed the CNAS on-site assessment, and the centre is expected to launch its testing services before September this year.